Hermetica Superfood Encyclopedia
The Short Answer
Ravintsara essential oil is dominated by 1,8-cineole (up to 37.7%) and linalool, which exert antimicrobial effects by disrupting bacterial membrane integrity and inhibiting respiratory chain enzymes in pathogens. In vitro antimicrobial studies demonstrate minimum inhibitory concentrations of 0.18–5.88 mg/ml against Gram-positive bacteria, placing its potency on par with its isolated major constituents linalool and 1,8-cineole alone.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary Keywordravintsara benefits
Ravintsara — botanical close-up
Health Benefits
**Antimicrobial Activity**
The essential oil demonstrates broad-spectrum antimicrobial action in vitro, with MIC values of 0.18–5.88 mg/ml (Tsaramandroso origin) against Gram-positive bacteria, driven primarily by 1,8-cineole and linalool disrupting microbial cell membranes.
**Respiratory Support**
1,8-cineole (eucalyptol), the dominant terpenoid in Mariarano-origin oil (37.7%), is a clinically recognized mucolytic and bronchodilatory agent used traditionally in Malagasy medicine for coughs and respiratory congestion.
**Digestive Relief**
Traditional Malagasy use includes application of leaf preparations for digestive complaints; monoterpenes such as limonene (7.83%) are associated with antispasmodic effects on smooth muscle in the gastrointestinal tract.
**Anti-poisoning and Detoxification**
Ravintsara is locally recognized for anti-poisoning applications, and terpene-rich essential oils have documented ability to modulate phase I/II detoxification enzyme activity in preclinical models.
**Anti-inflammatory Potential**
Linalool, a key alcohol terpene constituent, has demonstrated inhibition of pro-inflammatory cytokines (TNF-α, IL-6) and cyclooxygenase pathways in preclinical models, suggesting systemic anti-inflammatory potential.
**Antioxidant Properties**
The oxygenated monoterpene fraction of Cinnamosma fragrans essential oil contributes free radical scavenging activity, which may underpin some of the plant's traditional protective uses.
**Anxiolytic and Sedative Potential**
Linalool, present in significant concentrations especially in Tsaramandroso-origin oil, interacts with GABA-A receptors in preclinical studies, suggesting mild anxiolytic and calming properties relevant to aromatherapeutic applications.
Origin & History
Natural habitat
Cinnamosma fragrans is a small endemic tree of Madagascar, belonging to the Cannellaceae family, found predominantly in the northwestern humid forests of the island, including the Tsaramandroso and Mariarano regions. It thrives in tropical lowland and mid-elevation rainforest conditions with high humidity and rich lateritic soils. The plant is cultivated and wild-harvested by local Malagasy communities, with leaves steam-distilled to produce its aromatic essential oil, which is the primary commercial and medicinal product derived from the species.
“Ravintsara has been a cornerstone of Malagasy traditional medicine for generations, where the Malagasy name 'ravintsara' broadly translates to 'good leaf' or 'leaf that is good for everything,' reflecting its wide therapeutic regard across diverse ailments. Indigenous communities in northwestern Madagascar have employed the leaves in steam inhalations, poultices, and decoctions for respiratory illnesses, fevers, digestive disorders, and as an antidote in cases of suspected poisoning or food toxicity. The plant holds cultural significance as a sacred or protective botanical in some Malagasy communities, and healers (ombiasy) historically incorporated it into ceremonial purification and healing rituals. Ravintsara should be distinguished from the unrelated species Cinnamomum camphora, also called 'ravintsara' in older French phytotherapy literature from Madagascar, a source of longstanding taxonomic and nomenclatural confusion in Western aromatherapy markets.”Traditional Medicine
Scientific Research
The current body of scientific evidence for Cinnamosma fragrans is limited to in vitro antimicrobial studies and phytochemical characterization research, with no published randomized controlled clinical trials identified in the peer-reviewed literature as of 2024. Published studies have employed broth microdilution and disk diffusion assays to establish MIC values against bacteria including Staphylococcus aureus and Gram-positive species, with quantified MIC ranges of 0.18–11.75 mg/ml depending on geographic ecotype. Chemotypic variation between Tsaramandroso and Mariarano populations has been documented using GC-MS compositional analysis, establishing that linalool-dominant and 1,8-cineole-dominant chemotypes exist within the same species. Much of the mechanistic evidence cited for Ravintsara's specific therapeutic effects is extrapolated from well-characterized studies on its isolated major constituents (1,8-cineole, linalool, limonene) rather than from whole-extract clinical investigation.
Preparation & Dosage
Traditional preparation
**Steam-Distilled Essential Oil (Aromatherapy)**
2–5 drops diffused in a room diffuser for 30–60 minutes; primary route for respiratory applications.
**Topical Application (Diluted Essential Oil)**
1–3% dilution in a carrier oil (e.g., fractionated coconut or jojoba oil), applied to chest or back for respiratory congestion; not for undiluted skin contact.
**Traditional Leaf Infusion (Malagasy Folk Use)**
Dried or fresh leaves steeped in hot water for 10–15 minutes; consumed as an herbal tea for digestive complaints; no standardized dose established.
**Inhalation (Steam)**
3–5 drops of essential oil added to a bowl of hot water with a towel tent; inhaled for 5–10 minutes for mucolytic effect.
**Standardization**
No internationally standardized extract exists; commercial essential oils should specify chemotype (linalool-dominant vs. 1,8-cineole-dominant) and confirm GC-MS purity with minimum 35% total oxygenated monoterpene content.
**Dosage Note**
Effective supplemental dosing in humans has not been established through clinical trials specific to this species; dose guidance is currently empirical and practitioner-guided.
Nutritional Profile
Cinnamosma fragrans is utilized almost exclusively as an essential oil rather than as a dietary food source, so conventional macronutrient and micronutrient profiling is not applicable. The essential oil's principal phytochemicals include 1,8-cineole (eucalyptol, up to 37.7% in Mariarano ecotype), linalool (dominant in Tsaramandroso ecotype), limonene (approximately 7.83%), and a supporting matrix of oxygenated monoterpenes, sesquiterpenes, and monoterpene hydrocarbons. Bioavailability of inhaled 1,8-cineole is high via pulmonary absorption (plasma concentrations detectable within minutes of inhalation in human studies on pure 1,8-cineole), while dermal absorption of linalool through diluted topical preparations occurs at moderate rates. Leaf material consumed as an infusion would deliver trace amounts of these volatile constituents alongside chlorophylls, flavonoids, and tannins, though quantitative data for the leaf matrix of Cinnamosma fragrans specifically has not been fully characterized.
How It Works
Mechanism of Action
The primary bioactive mechanism of Ravintsara essential oil is attributed to 1,8-cineole (eucalyptol) and linalool acting synergistically to disrupt bacterial and fungal cell membrane phospholipid bilayers, increasing membrane permeability and causing leakage of intracellular contents. 1,8-Cineole additionally inhibits arachidonic acid metabolism via suppression of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) enzyme activity, reducing prostaglandin and leukotriene biosynthesis relevant to inflammation and respiratory mucus hypersecretion. Linalool modulates GABA-A receptor activity through allosteric binding, contributing to anxiolytic and antinociceptive effects observed in rodent models. Limonene, the tertiary constituent, activates Nrf2-mediated antioxidant response elements and has been shown to modulate hepatic CYP450 enzyme activity, which may partly explain traditional anti-poisoning applications.
Clinical Evidence
No clinical trials specifically investigating Cinnamosma fragrans as a whole extract or essential oil in human subjects have been identified in the indexed medical literature. The therapeutic claims associated with Ravintsara in respiratory and digestive medicine are currently supported by traditional ethnopharmacological evidence and extrapolation from clinical data on its major constituent 1,8-cineole, which has been evaluated in independent human trials for conditions including chronic obstructive pulmonary disease and sinusitis. For example, 1,8-cineole at doses of 200–400 mg three times daily has demonstrated statistically significant improvement in lung function and mucus clearance in small RCTs (n=20–60 participants), but these trials were not conducted with Ravintsara essential oil itself. Overall confidence in species-specific clinical efficacy remains low, and the ingredient should be categorized as traditionally used with preliminary mechanistic plausibility pending dedicated human trials.
Safety & Interactions
Ravintsara essential oil is generally considered safe when used at standard aromatherapeutic dilutions (1–3% in carrier oil) or as a steam inhalation; however, undiluted application to skin or mucous membranes can cause irritation or sensitization reactions due to its monoterpene content. The 1,8-cineole constituent is contraindicated for direct application to the face or inhalation in infants and young children under 2 years of age due to documented risk of respiratory depression and reflex apnea. Potential drug interactions include CYP450 enzyme modulation by limonene and 1,8-cineole, which may theoretically alter the metabolism of drugs with narrow therapeutic indices (e.g., anticoagulants, anticonvulsants, immunosuppressants) when consumed in significant quantities. No human safety studies or formal toxicological assessments specific to Cinnamosma fragrans have been published; pregnancy and lactation safety is unestablished and the essential oil should be avoided internally during these periods as a precautionary measure.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Cinnamosma fragransSaroGood LeafCannellaceae essential oilMalagasy camphor leaf
Frequently Asked Questions
What is the difference between ravintsara and ravensara?
Ravintsara refers to Cinnamosma fragrans (family Cannellaceae), a Malagasy endemic with an essential oil rich in 1,8-cineole and linalool, while ravensara refers to Ravensara aromatica (family Lauraceae), a related but distinct Malagasy species with a very different chemical profile dominated by methyl chavicol (estragole). This distinction is critically important because older French aromatherapy texts misapplied the name 'ravintsara' to Cinnamomum camphora, creating widespread confusion that persists in some commercial markets; consumers should verify GC-MS batch certificates when purchasing either oil.
Is ravintsara essential oil safe to use around children?
Ravintsara essential oil contains significant levels of 1,8-cineole (eucalyptol), which is contraindicated for direct facial application or close inhalation in children under 2 years of age due to the risk of triggering reflex apnea and respiratory depression. For older children (2–12 years), diluted topical use (0.5–1% in carrier oil) applied to the chest or upper back away from the face is considered a lower-risk approach, though no pediatric clinical safety data specific to Cinnamosma fragrans exists and parental caution and professional guidance are advised.
What are the main chemical compounds in ravintsara essential oil?
The dominant compounds in Ravintsara (Cinnamosma fragrans) essential oil are 1,8-cineole (eucalyptol), linalool, and limonene, though relative concentrations vary by geographic ecotype: Mariarano-region oil is 1,8-cineole-dominant (approximately 37.7%) with lower linalool (8.03%) and limonene (7.83%), while Tsaramandroso-region oil is linalool-dominant with 1,8-cineole as secondary. The oil also contains a supporting fraction of oxygenated monoterpenes, monoterpene hydrocarbons, and sesquiterpenes identified by GC-MS analysis.
What does ravintsara treat in traditional Malagasy medicine?
In traditional Malagasy ethnomedicine, Ravintsara (locally called 'Saro') is used primarily for respiratory conditions including coughs, bronchitis, and congestion, as well as for digestive complaints and as an anti-poisoning remedy following suspected food toxicity. Healers typically employ steam inhalations of the aromatic leaves or leaf decoctions for respiratory and fever management, while preparations for digestive and detoxification purposes are administered orally as infusions or decoctions, though formal documentation of traditional protocols is limited in the scientific literature.
How strong is the scientific evidence for ravintsara's health benefits?
The scientific evidence for Cinnamosma fragrans as a therapeutic agent is currently limited to in vitro antimicrobial assays and phytochemical characterization studies, with no published human clinical trials as of 2024. Antimicrobial MIC values (0.18–11.75 mg/ml depending on ecotype) have been quantified against bacteria in laboratory settings, and mechanistic plausibility for respiratory and anti-inflammatory effects is supported by well-established pharmacology of its major constituents (1,8-cineole, linalool) studied independently. Consumers should understand that Ravintsara's health claims rest primarily on traditional use and constituent-level extrapolation rather than direct clinical trial evidence.
Is ravintsara essential oil safe to use during pregnancy and breastfeeding?
Ravintsara essential oil is not recommended for internal use during pregnancy and breastfeeding due to insufficient safety data and the potential for 1,8-cineole to cross placental and mammary barriers. Topical application should only be considered under qualified practitioner guidance, and inhalation should be limited to well-ventilated spaces. Pregnant and nursing women should consult their healthcare provider before any use of ravintsara products.
Can ravintsara essential oil interact with medications like anticoagulants or immunosuppressants?
While direct drug interaction studies with ravintsara are limited, the constituent 1,8-cineole has been shown to affect hepatic metabolism via cytochrome P450 enzymes, potentially altering levels of anticoagulants, anticonvulsants, and immunosuppressants. Anyone taking prescription medications, particularly blood thinners or immune-modulating drugs, should consult a healthcare provider before using ravintsara internally. Topical or inhalation use carries lower interaction risk, but caution is still warranted with certain medication classes.
What is the proper dosage and duration for ravintsara essential oil use?
Recommended dosages vary by application method: inhalation via diffuser typically uses 2–5 drops per session for 15–30 minutes, while topical application should use 1–3% dilution in a carrier oil (1–3 drops per teaspoon). For internal use, doses of 1–2 drops diluted in water or taken in capsules are sometimes recommended, though this should only be done under professional supervision and never chronically without guidance. Most protocols suggest use for 2–4 weeks followed by a break to assess efficacy and minimize potential sensitization.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ravintsara-cinnamosma-fragrans curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
